ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Immunotherapy and the Future of Prostate Cancer Treatment – Cancer Therapy Advisor

Continue reading

2017-02-17 Michael Zand NEWS

Abortion law reform: Fears amendments to criminal code will fail – Courier Mail

Courier MailAbortion law reform: Fears amendments to criminal code will failCourier MailYet the law has been stranded in what can only be described as a state of suspended animation for more than three decades. While technically illegal and a grey area… Continue reading

2017-02-17 Michael Zand NEWS

Allergic Rhinitis: Three Years of Immunotherapy Gives Longer Lasting Symptom Control – MedicalResearch.com (blog)

Allergic Rhinitis: Three Years of Immunotherapy Gives Longer Lasting Symptom ControlMedicalResearch.com (blog)When nasal steroids and antihistamines do not work or cause side effects, allergen immunotherapy is an alternative. Immunotherapy using high d… Continue reading

2017-02-17 Michael Zand NEWS

CRISPR/Cas9 fight could be far from over – Seeking Alpha

Immunotherapy and the Future of Prostate Cancer Treatment
Cancer Therapy Advisor
ORLANDO, FL – Despite early failures, there may be a role for single-agent and combination immunotherapy for patients with prostate cancer, according to a keynote presentation at 2017 Genitourinary Cancers Symposium.1. Charles G. Drake, MD, PhD, …

Continue reading

2017-02-17 Michael Zand NEWS

Fight to the finish – India Today


BioWorld Online

CRISPR/Cas9 fight could be far from over
Seeking Alpha
*Despite the initial reaction from investors that stoked Wednesday’s nearly 30% spike in Editas Medicine (NASDAQ:EDIT), the dispute over who owns what related to patents covering gene editing technology CRISPR/Cas9 could drag on for some time.
Editas Medicine Inc (NASDAQ:EDIT) Reports USPTO Decision Positive To Broad Institute In CRISPR InterventionWallStreetPR

all 35 news articles »

Continue reading

2017-02-17 Michael Zand NEWS

Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials – Labiotech.eu (blog)

Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical TrialsLabiotech.eu (blog)Arthrogen will start a Phase Ib trial for a gene therapy aiming to treat rheumatoid arthritis with a single injection and reduce costs for patients. Arthroge… Continue reading

2017-02-17 Michael Zand NEWS

Gene Therapy Treatment Offered to Cancer Patients Saves Lives – TrendinTech

Fight to the finish
India Today
And if neither fails to muster the magic 118 figure, then the governor can keep the legislature in suspended animation by imposing President’s Rule. Of course, in the 1998 case, the governor had assumed the majority of one claimant was no more there …

Continue reading

2017-02-17 Michael Zand NEWS

Takeda, TiGenix stem cell therapy shows sustained effect – FierceBiotech


TrendinTech

Gene Therapy Treatment Offered to Cancer Patients Saves Lives
TrendinTech
While researchers and scientists work around the clock trying to put an end to the disease, sadly, there is still no cure. However, one new trial involving gene therapy treatment may bring a new wave hope to cancer patients and has already proved to be …
Gene Therapy and Antisense Drugs Market 2017 Research In-Depth Analysis, Applications, Forecasts To 2025Satellite PR News (press release)
Gene Editing Therapy May Help Cure CancerCounsel & Heal

all 3 news articles »

Continue reading

2017-02-17 Michael Zand NEWS
  • 1
  • …
  • 2,088
  • 2,089
  • 2,090
  • 2,091
  • 2,092
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

FierceBiotech

Takeda, TiGenix stem cell therapy shows sustained effect
FierceBiotech
Takeda and TiGenix have presented 52-week data on their allogeneic expanded adipose-derived stem cells in Crohn’s disease patients with treatment-refractory complex perianal fistulas. The data show the Cx601 stem cells continue to outperform placebo …
Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal …Business Wire (press release)

all 2 news articles »